AHA, Others Urge Congress to Reauthorize Health Care Preparedness Law
The Honorable Charles Schumer Majority Leader US Senate S-221 Capitol Building Washington, DC 20510 | The Honorable Mitch McConnell Minority Leader US Senate S-230 Capitol Building Washington, DC 20510 |
The Honorable Mike Johnson Speaker of the House US House of Representatives H-232 Capitol Building Washington, DC 20515 |
The Honorable Hakeem Jeffries Minority Leader US House of Representatives H-204 Capitol Building Washington, DC 20515 |
Re: The Urgent Need to Reauthorize PAHPA
Dear Leaders Schumer and McConnell, Speaker Johnson, and Leader Jeffries,
On behalf of the undersigned organizations, we write to express our strong desire to see the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorized before the end of the calendar year in the same bipartisan fashion it has been supported since the original authorization 17 years ago.
As you know, PAHPA underpins Department of Health and Human Services (HHS) agencies, programs, and funding authorizations for addressing national health security threats. PAHPA created the HHS Assistant Secretary for Preparedness and Response (now the Administration for Strategic Preparedness and Response) and the Biomedical Advanced Research and Development Authority (BARDA) and provides important congressional oversight and direction to federal programs related to early warning, prevention, preparedness, and response.
This overall framework expired on September 30, 2023, requiring stopgap, temporary extensions in the continuing resolution, which expires on November 17. We encourage Congress to include a comprehensive five-year PAHPA reauthorization in the next moving legislative vehicle.
The last three PAHPA bills all shared major recurring themes: they all adjusted to the changing threat landscape, focused on challenges identified since the prior bill, and considerably strengthened our nation’s health security with each reauthorization.
Our nation’s changing health security threat landscape and the federal government’s responsibility to protect the American people demand that we work together now to find a strong bipartisan path forward to reauthorize this critical legislation. Whether the next health security threat is naturally occurring, the result of an accident, or intentionally caused, our country must be in a better position to prevent, prepare for, and respond to such incidents.
Failing to reauthorize PAHPA would have serious effects on our country’s economic wellbeing, national security, and health security given the rapidly changing threat landscape.
We are hopeful that PAHPA will remain a strong bipartisan legislative framework, as it has always been. We stand ready to assist you in whatever ways we can to help get this important law reauthorized this year.
Sincerely (in alphabetical order),
1Day Sooner Acadian Ambulance Service, Inc. Adaptive Phage Therapeutics Aequor Inc. American Ambulance Association America’s Essential Hospitals American College of Emergency Physicians American College of Surgeons ºÚÁÏÕýÄÜÁ¿ Association American Lung Association American Pharmacies American Public Health Association American Society for Microbiology Arizona Bioindustry Association, Inc. (AZBio) Association for Professionals in Infection Control and Epidemiology Association of Maternal & Child Health Programs Association of State and Territorial Health Officials Asthma and Allergy Foundation of America AstraZeneca Pharmaceuticals ATCC (American Type Culture Collection) Atea Pharmaceuticals, Inc. Bavarian Nordic Big Cities Health Coalition BioCT Healthcare Leadership Council Healthcare Ready Helix HIMSS (Healthcare Information and Management Systems Society) HIV Medicine Association IAVI (International AIDS Vaccine Initiative) Illinois Biotechnology Innovation Organization Infectious Diseases Society of America INOVIO Pharmaceuticals Institute for Progress Johns Hopkins Center for Health Security Life Sciences PA Locus Biosciences Mallinckrodt Marked By Covid MassBio McKesson Medical Alley Medical Countermeasures Coalition Missouri Biotechnology Association (MOBIO) National Association of County and City Health Officials National Immigration Law Center New Mexico Biotechnoiogy & Biomedical Association (NMBio) New Orleans BioInnovation Center NewYorkBIO NightHawk Biosciences |
BioForward Wisconsin BioKansas BioNJ Biotechnology Innovation Organization (BIO) Bugworks Cencora Colorado BioScience Association Council of State and Territorial Epidemiologists Council of State Bioscience Associations (CSBA) CSL Seqirus Emergency Department Practice Management Association Emergent BioSolutions Federation of American Scientists FluGen Inc. Georgia Bio Gerontological Society of America Ginkgo Bioworks Global Health Investment Corporation Global Health Technologies Coalition Gryphon Scientific GSK Health Industry Distributors Association (HIDA) Healthcare Distribution Alliance Novavax Ochsner Health Ohio Life Sciences Association Oklahoma Bioscience Association PDS Biotechnology PharmaJet Inc. Premier Inc. Public Health Accreditation Board Research!America SAB Biotherapeutics, Inc. Sanofi SecureBio Shionogi Inc. SIGA Technologies, Inc. Society for Public Health Education Soligenix, Inc. Technologies for Pandemic Defense Texas Healthcare & Bioscience Institute Tonix Pharmaceuticals Trinity Health TrippBio, Inc. Trust for America’s Health United States Pharmacopeia (USP) University of Hawaii University of Maryland School of Medicine Valneva USA Vaxxas Inc Virginia Biotechnology Association |
cc:
Chair Bernie Sanders Health, Education, Labor & Pensions Committee US Senate |
Chair Cathy McMorris Rodgers Energy & Commerce Committee US House of Representatives |
Ranking Member Bill Cassidy Health, Education, Labor & Pensions Committee US Senate |
Ranking Member Frank Pallone Energy & Commerce Committee US House of Representatives |